773876

Hill Dermaceuticals, Inc. — FEI 1036365

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 30, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sanford, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
121521 CFR 211.67(b)Written procedures not established/followed
136121 CFR 211.100(a)Absence of Written Procedures
180921 CFR 211.160(a)Following/documenting laboratory controls
188321 CFR 211.165(a)Testing and release for distribution
191221 CFR 211.166(a)Written program not followed
192021 CFR 211.166(a)(3)Valid stability test methods
192221 CFR 211.166(a)(4)Testing in same container - closure system
200921 CFR 211.188Prepared for each batch, include complete information
203421 CFR 211.194(d)Laboratory equipment calibration records
440221 CFR 211.192Written record of investigation incomplete